Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
3,253
+503
+18% +$172K 0.12% 108
2026
Q1
$968K Buy
2,750
+4
+0.1% +$1.43K 0.11% 115
2025
Q4
$899K Buy
2,746
+17
+0.6% +$5.39K 0.1% 127
2025
Q3
$770K Hold
2,729
0.09% 135
2025
Q2
$762K Sell
2,729
-44
-2% -$12.5K 0.1% 132
2025
Q1
$864K Buy
2,773
+23
+0.8% +$6.79K 0.12% 114
2024
Q4
$717K Buy
2,750
+93
+4% +$27.6K 0.1% 124
2024
Q3
$856K Buy
2,657
+105
+4% +$34.3K 0.13% 105
2024
Q2
$797K Sell
2,552
-125
-5% -$36.7K 0.13% 103
2024
Q1
$761K Sell
2,677
-2,072
-44% -$606K 0.13% 104
2023
Q4
$1.37M Sell
4,749
-1,434
-23% -$391K 0.25% 74
2023
Q3
$1.66M Buy
6,183
+603
+11% +$150K 0.34% 59
2023
Q2
$1.24M Buy
5,580
+1,016
+22% +$236K 0.25% 75
2023
Q1
$1.1M Buy
4,564
+574
+14% +$141K 0.23% 84
2022
Q4
$1.05M Sell
3,990
-792
-17% -$212K 0.23% 87
2022
Q3
$1.08M Buy
4,782
+608
+15% +$147K 0.27% 78
2022
Q2
$1.02M Buy
4,174
+117
+3% +$28.7K 0.24% 86
2022
Q1
$981K Buy
4,057
+656
+19% +$151K 0.19% 105
2021
Q4
$765K Buy
3,401
+215
+7% +$45.4K 0.15% 123
2021
Q3
$678K Sell
3,186
-49
-2% -$11.3K 0.14% 122
2021
Q2
$789K Buy
3,235
+63
+2% +$15.5K 0.17% 114
2021
Q1
$789K Buy
3,172
+8
+0.3% +$1.91K 0.19% 107
2020
Q4
$727K Buy
3,164
+133
+4% +$30.7K 0.19% 107
2020
Q3
$770K Sell
3,031
-56
-2% -$13.9K 0.24% 95
2020
Q2
$728K Buy
3,087
+393
+15% +$89.7K 0.24% 92
2020
Q1
$546K Sell
2,694
-12
-0.4% -$2.62K 0.22% 99
2019
Q4
$652K Buy
2,706
+210
+8% +$46.3K 0.2% 107
2019
Q3
$483K Buy
2,496
+283
+13% +$54.3K 0.16% 127
2019
Q2
$408K Sell
2,213
-10
-0.4% -$1.79K 0.15% 128
2019
Q1
$422K Buy
2,223
+395
+22% +$75.4K 0.16% 122
2018
Q4
$356K Buy
1,828
+207
+13% +$40.4K 0.17% 121
2018
Q3
$336K Sell
1,621
-107
-6% -$21.1K 0.14% 131
2018
Q2
$319K Sell
1,728
-33
-2% -$5.84K 0.14% 132
2018
Q1
$300K Sell
1,761
-43
-2% -$7.89K 0.13% 143
2017
Q4
$314K Buy
1,804
+33
+2% +$5.84K 0.14% 139
2017
Q3
$330K Buy
1,771
+1,040
+142% +$184K 0.16% 123
2017
Q2
$126K Buy
731
+341
+87% +$55.5K 0.08% 172
2017
Q1
$64K Sell
390
-11,025
-97% -$1.83M 0.05% 188
2016
Q4
$1.67M Buy
11,415
+390
+4% +$58.7K 1.27% 22
2016
Q3
$1.84M Sell
11,025
-25
-0.2% -$4.23K 1.57% 15
2016
Q2
$1.68M Buy
11,050
+25
+0.2% +$3.89K 1.51% 14
2016
Q1
$1.65M Hold
11,025
1.51% 15
2015
Q4
$1.79M Buy
+11,025
New +$1.73M 1.6% 14

Other funds holding AMGN

Grove Bank & Trust's AMGN Position: Q2 2026 in Review

Grove Bank & Trust increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $172K and bringing the position to 3,253 shares worth $1.18M. The position accounts for 0.12% of the portfolio, ranked #108.

Grove Bank & Trust first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.84M in Q3 2016. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Grove Bank & Trust held 3,253 shares of Amgen worth $1.18M as of Q2 2026.
  • Grove Bank & Trust bought 503 Amgen shares in Q2 2026, an estimated $172K.
  • Amgen made up 0.12% of Grove Bank & Trust's portfolio in Q2 2026, its #108 holding.
  • Grove Bank & Trust first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
  • Grove Bank & Trust's Amgen position peaked at $1.84M in Q3 2016.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.